Quantinno Capital Management LP Has $8.04 Million Stock Position in The Chemours Company $CC

Quantinno Capital Management LP grew its holdings in The Chemours Company (NYSE:CC) by 16.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 364,745 shares of the specialty chemicals company’s stock after acquiring an additional 51,275 shares during the quarter. Quantinno Capital Management LP’s holdings in Chemours were worth $8,035,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CC. Atlas Capital Advisors Inc. bought a new position in Chemours during the fourth quarter worth about $26,000. Aster Capital Management DIFC Ltd acquired a new stake in Chemours in the 4th quarter worth about $28,000. Covestor Ltd boosted its holdings in Chemours by 204.7% in the 4th quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 1,748 shares during the period. Eurizon Capital SGR S.p.A. bought a new stake in Chemours in the 4th quarter valued at about $31,000. Finally, Rothschild Investment LLC grew its position in shares of Chemours by 87.0% during the 4th quarter. Rothschild Investment LLC now owns 2,698 shares of the specialty chemicals company’s stock worth $32,000 after purchasing an additional 1,255 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Chemours Stock Performance

Shares of Chemours stock opened at $17.94 on Wednesday. The company has a current ratio of 1.82, a quick ratio of 0.87 and a debt-to-equity ratio of 18.98. The company has a market cap of $2.70 billion, a PE ratio of -6.80 and a beta of 1.43. The company has a 50 day moving average of $19.67 and a 200-day moving average of $20.06. The Chemours Company has a 1-year low of $10.44 and a 1-year high of $28.67.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.08). Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the business earned ($2.54) earnings per share. The business’s revenue was down 1.5% compared to the same quarter last year. As a group, equities research analysts forecast that The Chemours Company will post 1.18 earnings per share for the current fiscal year.

Chemours Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Friday, August 14th will be issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend is Friday, August 14th. Chemours’s dividend payout ratio (DPR) is currently -13.26%.

Analyst Upgrades and Downgrades

CC has been the subject of a number of analyst reports. Mizuho dropped their price target on shares of Chemours from $30.00 to $25.00 and set an “outperform” rating for the company in a research report on Wednesday, July 1st. Truist Financial increased their price target on Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. JPMorgan Chase & Co. lifted their price objective on Chemours from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, May 21st. Zacks Research upgraded Chemours from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. Finally, Morgan Stanley increased their target price on Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Chemours presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.10.

Chemours News Summary

Here are the key news stories impacting Chemours this week:

• Positive Sentiment: Chemours generated $158 million in operating cash flow and $114 million in free cash flow during the second quarter. Titanium Technologies sales also increased 1% year over year, while the company cited growth opportunities tied to data-center demand. Chemours reports second-quarter sales and loss
• Positive Sentiment: Management maintained its 2026 outlook for 1% to 5% sales growth and adjusted EBITDA of $775 million to $825 million. Full-year revenue guidance of $5.9 billion to $6.1 billion is broadly in line with consensus. Chemours reports second-quarter results
• Neutral Sentiment: The board declared a quarterly dividend of $0.0875 per share, providing continued shareholder income but offering limited evidence of improving operating performance. Chemours announces third-quarter dividend
• Negative Sentiment: Second-quarter adjusted EPS was $0.42, below the $0.43 Zacks consensus and other analyst estimates near $0.50; earnings also declined from $0.58 a year earlier. Revenue fell 1% to $1.591 billion, and adjusted EBITDA decreased to $247 million from $260 million. Chemours misses second-quarter earnings and revenue estimates
• Negative Sentiment: Chemours reported a $274 million GAAP net loss, or $1.81 per share, with litigation costs weighing on results and overshadowing otherwise favorable data-center growth. Third-quarter revenue guidance of $1.5 billion to $1.6 billion is below the $1.6 billion consensus, reinforcing near-term execution concerns. Chemours litigation costs overshadow data-center growth

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.